To solidify the impact of NF-κB signaling on CXCR2-driven cancer progression, we employed CXCR2 shRNA to knockdown CXCR2 protein expression in SKCXCR2 cells and confirmed an inhibitory effect of CXCR2 shRNA. This evidence concerns the gene NFKB1 and cancer.